Trial of Foley Catheter With and Without Extra-Amniotic Saline Infusion for Labor Induction

Not Applicable

Completed

• Conditions: Labor Induction; Cervical Ripening

• Registration Number: NCT00442663
• Lead Sponsor: University of Alabama at Birmingham

Brief Summary

The purpose of this study is to compare the efficacy of a transcervical Foley catheter with and without extra-amniotic saline infusion (EASI) for priming the cervix for labor.

Detailed Description

In the United States, labor inductions have increased from 11% of all pregnancies in 1989 to 21% in 2004. Although the indications for labor induction vary, labor inductions as an obstetrical practice are associated with an increased risk of Cesarean delivery. As such, the rise in labor inductions has been paralleled by a rise in the cesarean rate to an all time high of 30%. The risk of cesarean can be mitigated with the use of cervical ripening agents in the setting of an unfavorable cervix. Both pharmacological ripening agents and mechanical methods are currently available for cervical priming. Methods available for mechanical dilation include, but are not limited to transcervical foley catheter alone and transcervical foley catheter with an extra-amniotic saline infusion or EASI. The potential advantage of EASI to transcervical foley catheter alone is the promotion of endogenous prostaglandin release by membrane stripping and supplying additional mechanical force. It may be disadvantageous by increasing the risk of chorioamnionitis or by diluting the prostaglandins that are released by membrane stripping. There have been two randomized trials comparing foley alone to foley with EASI. Because the results of these two trials are conflicting, we chose to conduct a randomized clinical trial of foley catheter compared to foley catheter with an EASI for labor induction and cervical ripening in women with an unfavorable cervix.

Study Timeline

• Study Start: 2003-06
• Study Completion: 2005-12
• Study First Submitted: 2007-02-28
• Study First Submitted QC: 2007-02-28
• Study First Posted: 2007-03-02
• Status Verified: 2007-04
• Last Update Submitted: 2007-04-23
• Last Update Posted: 2007-04-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 170

Inclusion Criteria

• Singleton pregnancy
• 24-42 weeks of gestation
• Cephalic presentation
• Intact membranes
• Bishop score of less than or equal to 6

Exclusion Criteria

• Contraindications to labor
• Dead or severely anomalous fetus
• Spontaneous labor.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Time from the start of labor induction to delivery

Secondary Outcome Measures

Name	Time	Method
Secondary maternal outcomes included cesarean delivery, chorioamnionitis and endometritis. Neonatal outcomes included birthweight, Apgar scores and cord blood gas analysis

Trial Locations

Locations (4)

University of Alabama at Birmingham; 🇺🇸 Birmingham, Alabama, United States

Saint Luke's Hospital; 🇺🇸 Kansas City, Kansas, United States

Truman Medical Center; 🇺🇸 Kansas City, Kansas, United States

Greenville Hospital System, University Medical Center; 🇺🇸 Greenville, South Carolina, United States